Finally, mTOR (mechanistic target of rapamycin) dysfunction has been identified as a contributing factor in human diseases such as amyotrophic lateral sclerosis (ALS), which was found to be associated with VCP mutations [24]. This evidence concerns the gene VCP and amyotrophic lateral sclerosis.